Doctor Supervised Weight Loss Injections in Palm Coast, FL
No Hidden Fees – No Insurance Needed
Your weight loss journey is not just about looking better in your clothes…it is about improving your overall health so you can enjoy life. Being overweight can also lead to many chronic health conditions like heart disease, high blood pressure, increased cancer risk, heart disease, back pain, etc.
A glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, Tirzepatide was approved by the FDA in March 2022 for use in adults with type 2 diabetes mellitus to improve glycemic control.
A comparative study compared Tirzepatide to Semaglutide showed an additional 24% reduction in HbA1c. Phase III trial results showed that Tirzepatide was neither inferior nor superior to Semaglutide with respect to the mean change in HbA1c from baseline to 40 weeks in patients with type 2 diabetes.
The results of the 40-week study also showed that Tirzepatide (5mg, 10mg, 15mg) outperformed Semaglutide (1mg) in reducing body weight. It was observed that up to 80% of users who took 5mg had at least a 5% (15lb) body weight reduction; at 10mg, 45% had a 10% (20lb) reduction; and at 15mg, up to 36% had a 15% (25lb) body weight reduction compared to 54%, 24%, and 8% of Semaglutide users.
The results of a 40-week study demonstrate that Tyrzepatide (5mg, 10mg, 15mg) offers at least 30%, 60%, and up to 95% greater weight loss than Semaglutide 1mg.
